Metabolomics profiling of AKT/c-Met-induced hepatocellular carcinogenesis and the inhibitory effect of Cucurbitacin B in mice
Hepatocellular carcinoma (HCC), the most common kind of liver cancer, accounts for the majority of liver cancer diagnoses and fatalities.Clinical aggressiveness, resistance to traditional therapy, and a high mortality rate are all features of this disease.Our previous studies have shown that co-activation of AKT and c-Met induces HCC development, i